Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 77.61K 72.44K 66.03K 125K 8.4M 126K 877K 340K 4.29M 328K 321K 13.78M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 218M 204M 186M 350M 23.62B 354M 2.47B 956M 12.08B 923M 903M 38.76B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.61%-3.43%+39.40%+112.31% 1,019B
-1.02%-5.60%+37.67%+65.02% 617B
+1.11%-0.58%+11.10%+77.28% 464B
+0.34%-3.01%+61.21%+40.71% 356B
-0.95%-4.05%+21.60%+39.37% 333B
-1.46%-2.89%+11.84%+24.60% 267B
-1.35%-5.43%-4.69%+8.40% 244B
-1.04%-2.79%+35.52%+51.34% 218B
-1.87%-4.10%+30.92%+95.33% 179B
Average -0.21%-3.05%+27.17%+57.15% 369.72B
Weighted average by Cap. +0.42%-3.33%+30.52%+68.96%

Financials

2016 2017
Net sales 54.27M 48.22M 45M 41.02M 77.36M 5.22B 78.08M 545M 211M 2.67B 204M 199M 8.56B 106M 94.13M 87.86M 80.08M 151M 10.18B 152M 1.06B 412M 5.21B 398M 389M 16.71B
Net income -103M -91.5M -85.4M -77.84M -147M -9.9B -148M -1.03B -400M -5.06B -387M -378M -16.24B -125M -111M -104M -94.64M -178M -12.04B -180M -1.26B -487M -6.15B -470M -460M -19.75B
Net Debt 209M 186M 174M 158M 299M 20.14B 301M 2.1B 815M 10.3B 787M 769M 33.04B 246M 218M 204M 186M 350M 23.62B 353M 2.47B 955M 12.07B 922M 902M 38.75B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock